MyFinsight
Home
Blog
About
Cash and cash
equivalents
$44,185K
(97.90%↑ Y/Y)
Marketable securities
$17,240K
Prepaid expenses and
other current assets
$9,895K
(37.45%↑ Y/Y)
Subtotal
$106K
(-22.06%↓ Y/Y)
Total current assets
$71,320K
(141.55%↑ Y/Y)
Right of use asset, net
$668K
(73.06%↑ Y/Y)
Property and equipment,
net
$41K
(-50.60%↓ Y/Y)
Less accumulated
depreciation
$65K
(22.64%↑ Y/Y)
Total assets
$72,029K
(140.14%↑ Y/Y)
Total liabilities and
stockholders equity
$72,029K
(140.14%↑ Y/Y)
Total stockholders
equity
$53,270K
(224.24%↑ Y/Y)
Total liabilities
$18,759K
(38.28%↑ Y/Y)
Accumulated deficit
-$142,370K
(-32.87%↓ Y/Y)
Accumulated other
comprehensive loss
-$23K
Additional paid-in capital
$195,635K
(58.47%↑ Y/Y)
Total current
liabilities
$18,704K
(37.87%↑ Y/Y)
Operating lease liability
long term
$55K
Common stock, 0.001 par
value per share ...
$28K
(-77.05%↓ Y/Y)
Warrant liability
$13,718K
(34.31%↑ Y/Y)
Accounts payable
$2,234K
(188.26%↑ Y/Y)
Accrued liabilities
$2,136K
(-1.48%↓ Y/Y)
Operating lease liability
- current
$616K
(50.61%↑ Y/Y)
Back
Back
Balance Sheet
Unicycive Therapeutics, Inc. (UNCY)
Unicycive Therapeutics, Inc. (UNCY)
source: myfinsight.com